EMA predicts drug shortages if third countries fail to meet new EU API rules
This article was originally published in SRA
Executive Summary
Some 50 drugs currently being marketed in the EU would clearly be at risk of shortage - and another 150 potentially at risk of shortage - if third country regulators fail to comply with requirements for active pharmaceutical ingredients that the EU falsified medicines legislation will introduce in July 20131.